11th Jan 2021 16:03
Income & Growth VCT PLC - venture capital trust - Sells investment in Bourn Bioscience Ltd to Canadian fund Triangle Health Care Partners 1 LP for GBP2.1 million cash. This contributes to a GBP1.0 million realised gain over cost over the life of the investment, equivalent to 0.87 pence per share. Over the life of the investment, Income & Growth VCT has received cash proceeds totalling GBP2.6 million, against a GBP1.6 million original cost. The isolated impact of the sale on Income & Growth VCT's September 30 net asset value per share of 70.06 pence would be a 1.34p per share increase.
Current stock price: 65.00 pence
Year-to-date change: unchanged
By Anna Farley; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Inc&gwth Vct